Health · Pharma & Biotech · 2 days ago
FDA approves first drug to treat narcolepsy itself
Narcolepsy is a sleep disorder that has often been treated as a joke or a comic plot point.
For people living with it, the reality is serious.
The US Food and Drug Administration has approved the first drug designed to treat narcolepsy itself, rather than only its symptoms.
That marks a change in how the condition can be treated.
Julie Flygare, who has narcolepsy and founded the non-profit Project Sleep, described what living with the condition is like and said the drug could be a gamechanger.
The approval could bring new hope to people with narcolepsy, though no further details about the drug or its next steps are given.
The US Food and Drug Administration approved the first drug to treat narcolepsy itself, rather than only its symptoms.
The approval could bring a change for people living with the sleep disorder.
Julie Flygare, who has narcolepsy and founded the non-profit Project Sleep, discussed what it is like to live with the condition.
Madeleine Finlay and Ian Sample discussed how the scientific breakthrough came about.
- Who
- The US Food and Drug Administration approved the drug.
- What
- It is the first drug approved to treat narcolepsy itself, rather than only its symptoms.
- When
- Not stated.
- Where
- The United States.
- Why
- It treats narcolepsy itself, rather than only its symptoms.
This story does not have two clearly opposing sides.
No direct quotes in the coverage so far.
This story does not have a timeline yet.
- Regulator
- US Food and Drug Administration
- First
- The first drug approved to treat narcolepsy itself
- Patient advocate
- Julie Flygare
- Non-profit
- Project Sleep
Sources
Related news
Idorsia presents new findings on blood pressure drug aprocitentan
Personalized cancer vaccine succeeds in phase 3 melanoma trial
Pilot trial tests support to limit weight regain after GLP-1 drugs stop
Dong-A launches three ibuprofen-based cold medicines
FDA approves atezolizumab with chemotherapy for some stage III colon cancers
Review links drug company gifts to more and less appropriate prescribing
Brazil suspends Peptistrong supplement and orders all batches recalled
Experimental injection reduced visceral fat by 12% in early trials
AstraZeneca blames trial design for failed bone disease drug study
Spain withdraws five erectile dysfunction supplements containing undeclared drugs
Baby Sleep Gripe Water Recalled After Alcohol Found in Testing
